Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 23 min ago
Peer-reviewedCC BYMolecular genetics & genomic medicine

Genetic Insights Into Cardiomyopathy With Restrictive Phenotype: Implications for Diagnosis and Personalized Care.

4 affiliations
  1. 1Department of Echocardiography, Zhongshan Hospital, Fudan University, Shanghai, China.
  2. 2Shanghai Institute of Cardiovascular Disease, Shanghai, China.
  3. 3Shanghai Institute of Medical Imaging, Shanghai, China.
  4. 4Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China.

Abstract

Background

Cardiomyopathy with a restrictive phenotype is uncommon, genetically heterogeneous, and difficult to distinguish from advanced hypertrophic or dilated cardiomyopathy. We aimed primarily to determine the diagnostic yield and spectrum of pathogenic or likely pathogenic variants among patients with an echocardiographically defined restrictive phenotype; genotype-imaging and survival comparisons were prespecified exploratory analyses.Methods

We screened 568 patients with cardiomyopathy who underwent whole-exome sequencing and comprehensive echocardiography. Thirty-three met the operational definition of restrictive phenotype. Variants were classified. Genotype-imaging associations and survival were analyzed exploratorily.Results

Among the 568 patients, 33 exhibited a restrictive phenotype: 7 had restrictive cardiomyopathy (RCM), 20 had hypertrophic cardiomyopathy with a restrictive phenotype (HRCM), and 6 had dilated cardiomyopathy with a restrictive phenotype (HDRCM). Variant carriers had a smaller aortic sinus diameter. In addition, MYBPC3 variant carriers had greater ventricular wall thickness and more frequent septal hypertrophy. Both the HRCM and HDRCM groups showed hypertrophic features, with interventricular septal hypertrophy occurring more frequently in the HDRCM group. The estimated 5-year survival was 54.5%, and survival did not differ significantly according to genetic-variant status.Conclusions

Pathogenic or likely pathogenic variants were frequent in this single-center cohort with restrictive physiology and were associated with selected imaging features. These exploratory findings support integrated genetic and echocardiographic evaluation.

Related

  1. Massive idiopathic myocardial calcification presenting with a restrictive cardiomyopathy phenotype: diagnostic challenges in the differential diagnosis of constrictive pericarditis
    T. Chalakova
    Българска кардиологияPeer-reviewedCC BYFull textCardiovascular medicineDOAJ
  2. A late bloom at the apex: development of apical hypertrophic cardiomyopathy phenotype in advanced age
    European heart journal. Case reportsPeer-reviewedCC BYFull textCardiovascular medicineEurope PMC
  3. Dual cardiac amyloidosis with AL cardiomyopathy and ATTR cardiomyopathy in systemic AL amyloidosis: Recommendation for a myocardial histology-based diagnosis
    Kazuki Fujioka, Tetsuji Kitano, Naoki Fujimoto +5
    Journal of cardiology casesPeer-reviewedCC BYFull textCardiovascular medicineEurope PMC
  4. Reading discordant bedside indices in sepsis-induced cardiomyopathy: an evidence-mapping framework for diagnosis and trial design
    Lulu Zhang, Siye Zhang
    Frontiers in cardiovascular medicinePeer-reviewedCC BYFull textCardiovascular medicineEurope PMC
  5. Atypical echocardiographic phenotype of end-stage hypertrophic cardiomyopathy: a case series
    Xi Wang, Qiuying Liu, Li Zhao +1
    Frontiers in cardiovascular medicinePeer-reviewedCC BYFull textCardiovascular medicineEurope PMCCrossref
BibTeX
@article{zhou2026genetic,
  title = {{Genetic Insights Into Cardiomyopathy With Restrictive Phenotype: Implications for Diagnosis and Personalized Care.}},
  author = {Nianwei Zhou and Yi Sun and Xuemei Wei and Wenwen Liang and Fangmin Meng and Zhengdan Ge and Minmin Sun and Xiaotong Cui and Shuning Zhang and Cuizhen Pan and Junbo Ge and Xianhong Shu},
  journal = {Molecular genetics \& genomic medicine},
  year = {2026},
  month = oct,
  doi = {10.1002/mgg3.70323},
  url = {https://europepmc.org/article/MED/42927652},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Genetic Insights Into Cardiomyopathy With Restrictive Phenotype: Implications for Diagnosis and Personalized Care.
AU  - Nianwei Zhou
AU  - Yi Sun
AU  - Xuemei Wei
AU  - Wenwen Liang
AU  - Fangmin Meng
AU  - Zhengdan Ge
AU  - Minmin Sun
AU  - Xiaotong Cui
AU  - Shuning Zhang
AU  - Cuizhen Pan
AU  - Junbo Ge
AU  - Xianhong Shu
PY  - 2026
DA  - 2026/10/30
JO  - Molecular genetics & genomic medicine
DO  - 10.1002/mgg3.70323
UR  - https://europepmc.org/article/MED/42927652
AB  - Background  Cardiomyopathy with a restrictive phenotype is uncommon, genetically heterogeneous, and difficult to distinguish from advanced hypertrophic or dilated cardiomyopathy. We aimed primarily to determine the diagnostic yield and spectrum of pathogenic or likely pathogenic variants among patients with an echocardiographically defined restrictive phenotype; genotype-imaging and survival comparisons were prespecified exploratory analyses.Methods  We screened 568 patients with cardiomyopathy who underwent whole-exome sequencing and comprehensive echocardiography. Thirty-three met the operational definition of restrictive phenotype. Variants were classified. Genotype-imaging associations and survival were analyzed exploratorily.Results  Among the 568 patients, 33 exhibited a restrictive phenotype: 7 had restrictive cardiomyopathy (RCM), 20 had hypertrophic cardiomyopathy with a restrictive phenotype (HRCM), and 6 had dilated cardiomyopathy with a restrictive phenotype (HDRCM). Variant carriers had a smaller aortic sinus diameter. In addition, MYBPC3 variant carriers had greater ventricular wall thickness and more frequent septal hypertrophy. Both the HRCM and HDRCM groups showed hypertrophic features, with interventricular septal hypertrophy occurring more frequently in the HDRCM group. The estimated 5-year survival was 54.5%, and survival did not differ significantly according to genetic-variant status.Conclusions  Pathogenic or likely pathogenic variants were frequent in this single-center cohort with restrictive physiology and were associated with selected imaging features. These exploratory findings support integrated genetic and echocardiographic evaluation.
SN  - 2324-9269
ER  -